|Articles|August 30, 2016
CMIC HOLDINGS Implements goBalto Activate
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.
Advertisement
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia. The CRO looks for the solution to improve workflows of studies being conducted in Malaysia, Singapore, Taiwan, Philippines, Thailand, Japan and South Korea.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5